Peter Jenner
Affiliations: | Pharmacology | Kings College London, London, England, United Kingdom |
Google:
"Peter Jenner"Mean distance: 16.83 (cluster 11)
Children
Sign in to add trainee| Emma L. Lane | grad student | Kings College London | |
| Abderrezzaq Soltani | grad student | (Chemistry Tree) | |
| Debbie Dewar | grad student | 1980-1984 |
Collaborators
Sign in to add collaborator| Chris J Carter | collaborator | 1979-1984 | Institute of Psychiatry (IOP), King's College London |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rota S, Boura I, Batzu L, et al. (2020) "Dopamine Agonist Phobia" in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine. Expert Review of Neurotherapeutics |
| Sportelli C, Urso D, Jenner P, et al. (2020) Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-Viewpoint. Frontiers in Neurology. 11: 556 |
| van Wamelen DJ, Wan YM, Ray Chaudhuri K, et al. (2020) Stress and cortisol in Parkinson's disease. International Review of Neurobiology. 152: 131-156 |
| van Wamelen DJ, Taddei RN, Calvano A, et al. (2020) Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson's Disease. Journal of Parkinson's Disease |
| Chaudhuri KR, Jenner P, Antonini A. (2019) Reply to: "Parkinson disease-associated dyskinesia in countries with low access to levodopa-sparing Regimens". Movement Disorders : Official Journal of the Movement Disorder Society. 34: 1930-1931 |
| Asser A, Hikima A, Raki M, et al. (2019) Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusers. Journal of Neural Transmission (Vienna, Austria : 1996) |
| Leta V, Jenner P, Chaudhuri KR, et al. (2019) Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update. Expert Opinion On Drug Safety |
| Coletto E, Dolan JS, Pritchard S, et al. (2019) Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease. Npj Parkinson's Disease. 5: 10 |
| Chaudhuri KR, Jenner P, Antonini A. (2019) Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society |
| Antonini A, Jenner P. (2018) Apomorphine infusion in advanced Parkinson disease. Nature Reviews. Neurology |